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The Great Coronavirus Pandemic of 2020—7 Critical Lessons
Lawrence O. Gostin, JD
The world is experiencing a once-in-a - l i fe t i m e p a n d e m i c , c a u s i nguntold human suffering and death,
unraveling of social relationships, and rob-
bing individuals of livelihoods and coun-
tries of prosperity. The coronavirus pan-
demic has strained health systems,
revealed unconscionable inequalities, and
upended international institutions. Here
are 7 critical lessons.
First, Build Resilient Health Systems
The most important element of pandemic
preparedness is a resilient health system to
rapidly detect, assess, report, and respond
to novel outbreaks. The International Health
Regulations, which govern pandemic re-
sponse, require all countries to have core
health system capacities, including surveil-
lance, laboratories, human resources, and
risk communication. Health systems also
need capacity to test for, diagnose, and treat
infectious diseases.
Although high-income countries have
robust health systems, they often lacked
sufficient capacity to treat large numbers
of patients with coronavirus disease 2019
(COVID-19) or to protect health workers
from infection. In the US, hospitals and
governors had to compete for access
to ventilators and personal protective
equipment. Resilient health systems
require surge capacity to cope with health
emergencie s in the event hospitals
become overrun.
Second, Leadership and Public Trust
Are the Single Greatest Indicator
of Success
Although health systems are important,
COVID-19 demonstrated that even coun-
tries with strong capacities often per-
formed badly. The Global Health Security
Index, for example, ranked the US first
in the world for pandemic preparedness.
Yet, as of August 12, the US had reported
more than 5 mill ion cases, the most
COVID-19 cases and deaths globally—2 mil-
lion more than Brazil, which was second,
and far ahead of the more than 300 000
cases in each of the 2 hardest hit European
nations, Spain and the United Kingdom.
The coronavirus pandemic teaches that
leadership is crucial. Perhaps the single
greatest indicator of success in responding
to COVID-19 has been whether govern-
ments gain the public’s trust. Population-
based health behaviors—handwashing and
other aspects of personal hygiene, physi-
cal distancing, and face coverings—can sig-
nificantly reduce community spread.
Third, Defend the Integrity of Science
and Public Health Agencies
Science has enabled societies to under-
stand the virus, its modes of transmission,
and most effective public health interven-
tions. Within weeks of reports of a cluster of
atypical pneumonia cases in Wuhan,
China, scientists had sequenced the virus.
Epidemiological studies subsequently
determined severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2) infec-
tion was transmitted person to person,
including by asymptomatic individuals.
Further research showed that personal
hygiene, physical distancing, and face cov-
erings were effective nontherapeutic
interventions. Research laboratories rap-
idly developed viral and antibody testing
technologies. There is promising scientific
research into effective vaccines and thera-
peutics. Within 6 months, 6 vaccine
candidates were in phase 3 clinical trials.
Despite remarkable, albeit incomplete,
scientific discovery, populist political lead-
ers have sown doubt about the value of
science and have undermined public
health agencies. In Brazil and the US, for
example, political leaders have publicly
recommended COVID-19 treatments that
their own agencies have not approved,
such as hydroxychloroquine. President
Trump publicly criticized US Centers for
Disease Control and Prevention guidelines
for reopening schools. If political leaders
fail to implement evidence-based policies
or to convey consistent messages based
on science, the pandemic response will
be suboptimal.
Fourth, Invest in Biomedical Research
and Development
The integrity of science is necessary but
insufficient. Governments must sustain-
ably invest in biomedical research and
development, not just during a health cri-
sis but also during interpandemic periods.
After the West Africa Ebola epidemic, the
Commission on a Global Health Risk
Framework for the Future recommended
an incremental increase of $1 billion per year
to accelerate research and development
for innovative medical technologies. Even
$1 billion annually is far too low given
the economic devastation of the pan-
demic, with the World Bank projecting a
5.2% contraction in global GDP in 2020.
A World Health Organization (WHO) initia-
tive, the R&D Blueprint for COVID-19,
shows the vast undertaking needed to
develop safe and effective therapeutics
and vaccines.
Fifth, Focus on Equity: The Prevailing
Narrative of This Age
Even before the coronavirus pandemic,
social, economic, and health inequities
became the prevailing global narrative.
Yet, COVID-19 amplified long-standing
systemic inequalities, including access to
health care. SARS-CoV-2 infections and
COVID-19 deaths disproportionately affected
racial minorities including Black, Hispanic,
and Native American individuals. Many
lower-paid workers, such as those in gro-
cery stores, meatpacking plants, and truck
drivers, were exposed to individuals with
SARS-CoV-2 infection.
Also, although many white-collar pro-
fessionals could work remotely with a
secure income, lower-income US workers
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US unemployment rose from 3.8% in
Februar y to 13% in May. Infec t ious
diseases should affect populations simi-
larly, but COVID-19 demonstrated that
low-income people, those who are less
educated, and racial minorities are dispro-
portionately affected. It is unsurprising
that the Black Lives Matter protests coin-
cided with the COVID-19 pandemic. Popu-
lations everywhere are expressing anger
with enduring health, social, and eco-
nomic injustices.
Sixth, Adopt Evidence-Based Laws:
Safeguard the Rule of Law
State laws have long authorized public
health powers to test, trace, isolate, and
quarantine. These traditional powers can be
expanded in declared emergencies. Public
health laws are narrow and measured, re-
quiring individual assessments of risk. Yet,
the COVID-19 response has gone beyond
anything seen since the 1918-1919 influ-
enza pandemic. It was previously unimagi-
nable that the government could lockdown
an entire city the size of New York or
Los Angeles. Yet, in April, more than half of
all US residents were under stay-at-home or-
ders. Mayors and governors closed down all
nonessential businesses. Currently, nearly
half the states have imposed interstate travel
restrictions requiring travelers to self-
quarantine for 14 days.
These sweeping powers have not
been definitively tested. The US Supreme
Court has ruled on COVID-19–related cases
in relation to voting and religious freedom,
but it has not yet opined on the liberty-
limiting regulations imposed during the
COVID-19 re sponse. Re sponding to
expansions of political power in countries like
Russia, Turkey, and Hungary, the United
Nations launched a Rule of Law project on
COVID-19. Emergency health powers
should be based on evidence and used
only when there are no less restrictive
alternatives. Usurpation of power under
the pretext of a health crisis threatens to
erode democratic freedoms, which can
endure even after the crisis ends.
Seventh, Fund and Support Robust
Global Institutions: We Are in This
Together
A once-in-a-lifetime threat that all the
world shares in common should bring
people and nations together. Yet the
COVID-19 pandemic has frayed interna-
tional relations. In the midst of a historic
pandemic, 2 superpowers—China and the
US—blamed one another, even at the World
Health Assembly. In July, President Trump
notified the UN General Secretary the US
would withdraw from the WHO.
Yet, there are also hopeful signs of inter-
national cooperation. Public and private part-
ners joined with the WHO to launch the
Access to COVID-19 Tools (ACT) Accelerator,
a global collaboration to accelerate research
and development, production, and equi-
table access to COVID-19 tests, treatments,
and vaccines. COVAX—a partnership be-
tween Gavi, the Coalition for Epidemic Pre-
paredness Innovations, and the WHO—is the
vaccine arm of ACT, designed to facilitate
the discovery of COVID-19 vaccines and guar-
antee fair and equitable global access.
Governments and international institu-
tions have clear choices on how best to re-
spond to COVID-19 and to prepare for fu-
ture pandemics. Choosing science, the rule
of law, and equity as core values would be
transformational. Building universal health
systems would not only prepare countries
for epidemic response, it would also vastly
improve the health and well-being for all
people, across the full spectrum of health
threats faced by humankind.
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